Free Trial
ASX:SHL

Sonic Healthcare (SHL) Stock Price, News & Analysis

Sonic Healthcare logo

About Sonic Healthcare Stock (ASX:SHL)

Advanced Chart
Remove Ads

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
1.46 million shs
Average Volume
N/A
Market Capitalization
$13.84 billion
P/E Ratio
26.85
Dividend Yield
3.68%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Sonic Healthcare Limited offers medical diagnostic services to medical practitioners, hospitals, community health services, and their collective patients. The company provides laboratory medicine/pathology testing services, such as biochemistry, cytopathology, genetics, haematology, histopathology, immunoserology, microbiology, molecular pathology, prenatal testing, toxicology, and ancillary functions; and radiology services, including magnetic resonance imaging, computed tomography (CT), ultrasound, X-ray, mammography, nuclear medicine, PET CT, interventional procedures, and bone mineral densitometry. It offers primary care medical services comprising general practice clinics, occupational health services, skin cancer clinics, after-hours general practice services, general practice IT solutions, and community-based healthcare services. The company operates in Australia, the United Kingdom, Ireland, the United States, Germany, Switzerland, New Zealand, Belgium, and internationally. Sonic Healthcare Limited was incorporated in 1934 and is headquartered in Sydney, Australia.

Remove Ads
Receive SHL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sonic Healthcare and its competitors with MarketBeat's FREE daily newsletter.

SHL Stock News Headlines

Jefferies Sticks to Its Hold Rating for Sonic Healthcare Limited (SHL)
New “Trump” currency proposed in DC
According to one of the most connected men in Washington… A surprising new bill was just introduced in Washington. Its purpose: to put Donald Trump’s face on the $100 note. All to celebrate a new “golden age” for America.
Morgans Sticks to Their Buy Rating for Sonic Healthcare Limited (SHL)
Jefferies Keeps Their Hold Rating on Sonic Healthcare Limited (SHL)
See More Headlines

SHL Stock Analysis - Frequently Asked Questions

Sonic Healthcare Limited (ASX:SHL) released its quarterly earnings results on Wednesday, February, 20th. The health services provider reported $0.52 EPS for the quarter, missing analysts' consensus estimates of $0.56 by $0.04. Sonic Healthcare had a net margin of 5.72% and a trailing twelve-month return on equity of 6.54%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Sonic Healthcare investors own include CSL (CSL), BHP Group (BHP), Commonwealth Bank of Australia (CBA), Contact Energy (CEN), Fortescue (FMG), Meta Platforms (META) and Mineral Resources (MIN).

Company Calendar

Last Earnings
2/20/2019
Ex-Dividend for 3/19 Dividend
3/04/2025
Record date for 3/19 Dividend
3/19/2025
Dividend Payable
3/19/2025
Today
4/02/2025

Industry, Sector and Symbol

Stock Exchange
ASX
Sector
Medical
Industry
Diagnostics & Research
Sub-Industry
N/A
Current Symbol
ASX:SHL
CIK
N/A
Fax
N/A
Employees
41,000
Year Founded
N/A

Profitability

Trailing P/E Ratio
26.85
Forward P/E Ratio
N/A
P/E Growth
-1.19
Net Income
$511.09 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$8.97 billion
Price / Cash Flow
28.91
Book Value
A$16.96 per share
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$13.84 billion
Optionable
Not Optionable
Beta
0.51
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?

Get This Free Report

This page (ASX:SHL) was last updated on 4/2/2025 by MarketBeat.com Staff
From Our Partners